BICO GROUP AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.24 SEK | -1.73% |
|
+0.55% | -22.33% |
Presentation Operator MessageOperator (Operator)Good morning, and welcome to the BICO Q1 FY 20...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company's operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Calendar
2024-05-07
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
44.24
SEK
Average target price
132.5
SEK
Spread / Average Target
+199.50%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -22.33% | 291M | |
| +2.64% | 207B | |
| +1.80% | 175B | |
| +8.59% | 132B | |
| +16.47% | 99.1B | |
| -3.42% | 60.89B | |
| +12.71% | 52.04B | |
| -6.61% | 45.48B | |
| -4.53% | 38.81B | |
| +9.27% | 38.77B |
- Stock Market
- Equities
- BICO Stock
- News BICO Group AB
- Transcript : BICO Group AB, Q2 2022 Earnings Call, Aug 24, 2022
